Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NanoRet

Financiado

Cerrado

Nanocarriers Optimization for Periocular Drug Delivery to the Retina

The incidence of chronic vision-impairing retinal diseases is increasing due to population ageing. Monthly intraocular injections are the standard of care, despite the important risks (e.g., infection and haemorrhage) associated w... ver más

31/10/2026

UNIVERSITA DEGLI S...

Presupuesto desconocido

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PARMA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-11-01

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

UNIVERSITA DEGLI STUDI DI PA...

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NANOIDROPS Nucleic acid nanoparticles for topical ophthalmic drug deliv... 168K€ Cerrado

LIPOmRNA ModeRN Approach to ocular disease treatment - Smart lipid-ba... 200K€ Cerrado

EEBB-I-12-05371 COMBINACION DE HIDROGELES BIOMIMETICOS Y NANOPARTICULAS COMO... 6K€ Cerrado

BES-2011-046381 COMBINACION DE HIDROGELES BIOMIMETICOS Y NANOPARTICULAS COMO... 41K€ Cerrado

MAT2013-47501-C2-1-R DESARROLLO DE APROXIMACIONES TERAPEUTICAS BASADAS EN PLATAFO... 176K€ Cerrado

EUIN2013-51165 DESARROLLO DE NUEVAS HERAMIENTAS DE DIAGNOSTICO PARA LA EVAL... 11K€ Cerrado

Duración del proyecto: 23 meses Fecha Inicio: 2024-11-01
Fecha Fin: 2026-10-31

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PARMA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The incidence of chronic vision-impairing retinal diseases is increasing due to population ageing. Monthly intraocular injections are the standard of care, despite the important risks (e.g., infection and haemorrhage) associated with this practice. A promising alternative is the periocular injection of nanocarriers, which are able to enhance the permeability across the ocular membranes. However, as periocular administration relies on the drug transport mechanisms in the tissues to reach the target, animal tests are generally needed for a prediction of drug distribution after the injection.The researcher aims at the development of an ex vivo model of a whole porcine eye which will constitute an evaluation tool for periocular nanoformulations targeting the retina and will allow for a deep understanding of the ocular penetration paths. The project will (i) provide a safer alternative to intraocular injections, (ii) reduce the need for animal testing in the pre-clinical phase of product development and (iii) overcome the current limitations of mathematical models, which are generally unable to predict the complexity of nanoformulations transport. This MSCA will be implemented throughout 24 months at the University of Parma, and it will include two 3-months secondments: the researcher will be trained on pharmacokinetics mathematical models at the University of Navarra and on Organs-on-a-Chip models at Tel Aviv University. The selected methodology allows for a cutting-edge approach to nanoparticles design, promoting the synergistic use of chemistry tools (spectroscopy) with medicine and biology (ex vivo models, 3D imaging, cellular assays) and engineering tools (mathematical models, Organs-on-a-Chip).The competencies acquired during the project will complement the researcher’s background towards the ultimate goal of becoming an expert in the development of innovative and effective ophthalmic therapeutics, with a focus on alternative methods to animal testing.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores